Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PMA submissions up almost 60% to 70 applications in FY 1997 - - ODE annual report.

This article was originally published in The Gray Sheet

Executive Summary

PMA SUBMISSIONS INCREASE NEARLY 60% TO 70 APPLICATIONS IN FY 1997, according to the annual report released by FDA's Office of Device Evaluation the week of Feb. 2. The 70 premarket approval applications received in fiscal year 1997 (ended Sept. 31) compares to 44 submitted in 1996 and is the most submitted since 1991. Of the 74 PMA-related filing decisions made during FY 1997, over 75% (58) were accepted for filing, the highest percentage in over 10 years. Nearly the same percentage of PMAs (72%, or 48) were approved, and 14 PMAs (21%) were deemed approvable.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel